当前位置:首页 - 行情中心 - 奥泰生物(688606) - 财务分析

奥泰生物

(688606)

  

流通市值:53.88亿  总市值:53.88亿
流通股本:7928.09万   总股本:7928.09万

奥泰生物(688606)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.90亿元,每股收益2.39元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益390134.75万元,未分配利润190571.99万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产424202.63万元,负债34067.89万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入633,076,568.3429,850,024.75208,475,751.58866,582,952.58
营业总成本457,636,927.5299,110,577.78143,277,319.88571,937,182.55
其他经营收益
营业利润218,808,577.65152,580,872.9164,574,780.95345,517,902.88
利润总额218,245,963.24152,107,387.7464,519,821.47347,713,380.13
净利润189,723,134.17132,101,804.8661,179,020.99302,909,852.72
每股收益
其他综合收益-608,935.67-647,348.27-276,672.561,762,140.42
综合收益总额189,114,198.5131,454,456.5960,902,348.43304,671,993.14
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,927,645,354.462,890,971,208.92,975,552,738.882,965,299,324.77
非流动资产:
非流动资产合计1,314,380,983.961,263,041,140.271,229,317,687.351,220,720,833.48
资产总计4,242,026,338.424,154,012,349.174,204,870,426.234,186,020,158.25
流动负债:
流动负债合计329,541,409.28243,218,757.13254,296,046.66299,188,026.93
非流动负债:
非流动负债合计11,137,443.033,036,861.452,889,110.23,411,828.43
负债合计340,678,852.31246,255,618.58257,185,156.86302,599,855.36
所有者权益(或股东权益):
归属于母公司股东权益合计3,901,773,832.633,907,884,829.093,947,946,975.673,883,641,163.49
股东权益合计3,901,347,486.113,907,756,730.593,947,685,269.373,883,420,302.89
负债和股东权益合计4,242,026,338.424,154,012,349.174,204,870,426.234,186,020,158.25
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计671,775,561.77450,978,874.54218,921,277.15947,267,500.11
经营活动现金流出小计557,315,959.78389,625,238.79208,176,086.98617,745,627.06
经营活动产生的现金流量净额114,459,601.9961,353,635.7510,745,190.17329,521,873.05
投资活动产生的现金流量:
投资活动现金流入小计1,661,986,279.021,340,220,271.23599,607,891.82,405,867,513.71
投资活动现金流出小计1,582,074,613.041,094,140,912.37634,092,496.012,884,922,916.2
投资活动产生的现金流量净额79,911,665.98246,079,358.86-34,484,604.21-479,055,402.49
筹资活动产生的现金流量:
筹资活动现金流入小计10,357,453.013,396.29-8,972,778.7
筹资活动现金流出小计118,677,423.8118,143,367.6-281,705,836.11
筹资活动产生的现金流量净额-108,319,970.79-118,139,971.31--272,733,057.41
汇率变动对现金及现金等价物的影响-5,492,523.53-630,750.5-365,488.395,978,316.56
现金及现金等价物净增加额80,558,773.65188,662,272.8-24,104,902.43-416,288,270.29
期末现金及现金等价物余额980,895,729.241,088,999,228.39876,232,053.16900,336,955.59
补充资料:
现金及现金等价物的净增加额-188,662,272.8--416,288,270.29
TOP↑